149 related articles for article (PubMed ID: 25736522)
1. Distinct localizations and roles of non-muscle myosin II during proplatelet formation and platelet release.
Badirou I; Pan J; Souquere S; Legrand C; Pierron G; Wang A; Eckly A; Roy A; Gachet C; Vainchenker W; Chang Y; Léon C
J Thromb Haemost; 2015 May; 13(5):851-9. PubMed ID: 25736522
[TBL] [Abstract][Full Text] [Related]
2. Carboxyl-terminal-dependent recruitment of nonmuscle myosin II to megakaryocyte contractile ring during polyploidization.
Badirou I; Pan J; Legrand C; Wang A; Lordier L; Boukour S; Roy A; Vainchenker W; Chang Y
Blood; 2014 Oct; 124(16):2564-8. PubMed ID: 25185263
[TBL] [Abstract][Full Text] [Related]
3. Megakaryocyte migration defects due to nonmuscle myosin IIA mutations underlie thrombocytopenia in MYH9-related disease.
Pal K; Nowak R; Billington N; Liu R; Ghosh A; Sellers JR; Fowler VM
Blood; 2020 May; 135(21):1887-1898. PubMed ID: 32315395
[TBL] [Abstract][Full Text] [Related]
4. Myosin IIA is critical for organelle distribution and F-actin organization in megakaryocytes and platelets.
Pertuy F; Eckly A; Weber J; Proamer F; Rinckel JY; Lanza F; Gachet C; Léon C
Blood; 2014 Feb; 123(8):1261-9. PubMed ID: 24243973
[TBL] [Abstract][Full Text] [Related]
5. The abnormal proplatelet formation in MYH9-related macrothrombocytopenia results from an increased actomyosin contractility and is rescued by myosin IIA inhibition.
Chen Y; Boukour S; Milloud R; Favier R; Saposnik B; Schlegel N; Nurden A; Raslova H; Vainchenker W; Balland M; Nurden P; Debili N
J Thromb Haemost; 2013 Dec; 11(12):2163-75. PubMed ID: 24165359
[TBL] [Abstract][Full Text] [Related]
6. Regulation of platelet biogenesis: insights from the May-Hegglin anomaly and other MYH9-related disorders.
Chen Z; Shivdasani RA
J Thromb Haemost; 2009 Jul; 7 Suppl 1():272-6. PubMed ID: 19630815
[TBL] [Abstract][Full Text] [Related]
7. Nonmuscle myosin II isoform and domain specificity during early mouse development.
Wang A; Ma X; Conti MA; Liu C; Kawamoto S; Adelstein RS
Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14645-50. PubMed ID: 20679233
[TBL] [Abstract][Full Text] [Related]
8. Proplatelet formation deficit and megakaryocyte death contribute to thrombocytopenia in Myh9 knockout mice.
Eckly A; Rinckel JY; Laeuffer P; Cazenave JP; Lanza F; Gachet C; Léon C
J Thromb Haemost; 2010 Oct; 8(10):2243-51. PubMed ID: 20695978
[TBL] [Abstract][Full Text] [Related]
9. Myosin-II inhibition and soft 2D matrix maximize multinucleation and cellular projections typical of platelet-producing megakaryocytes.
Shin JW; Swift J; Spinler KR; Discher DE
Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11458-63. PubMed ID: 21709232
[TBL] [Abstract][Full Text] [Related]
10. Importance of environmental stiffness for megakaryocyte differentiation and proplatelet formation.
Aguilar A; Pertuy F; Eckly A; Strassel C; Collin D; Gachet C; Lanza F; Léon C
Blood; 2016 Oct; 128(16):2022-2032. PubMed ID: 27503502
[TBL] [Abstract][Full Text] [Related]
11. Myosin II tailpiece determines its paracrystal structure, filament assembly properties, and cellular localization.
Ronen D; Ravid S
J Biol Chem; 2009 Sep; 284(37):24948-57. PubMed ID: 19553683
[TBL] [Abstract][Full Text] [Related]
12. The May-Hegglin anomaly gene MYH9 is a negative regulator of platelet biogenesis modulated by the Rho-ROCK pathway.
Chen Z; Naveiras O; Balduini A; Mammoto A; Conti MA; Adelstein RS; Ingber D; Daley GQ; Shivdasani RA
Blood; 2007 Jul; 110(1):171-9. PubMed ID: 17392504
[TBL] [Abstract][Full Text] [Related]
13. A point mutation in Myh10 causes major defects in heart development and body wall closure.
Ma X; Adelstein RS
Circ Cardiovasc Genet; 2014 Jun; 7(3):257-65. PubMed ID: 24825879
[TBL] [Abstract][Full Text] [Related]
14. Dysmegakaryopoiesis of FPD/AML pedigrees with constitutional RUNX1 mutations is linked to myosin II deregulated expression.
Bluteau D; Glembotsky AC; Raimbault A; Balayn N; Gilles L; Rameau P; Nurden P; Alessi MC; Debili N; Vainchenker W; Heller PG; Favier R; Raslova H
Blood; 2012 Sep; 120(13):2708-18. PubMed ID: 22898599
[TBL] [Abstract][Full Text] [Related]
15. Myosin regulatory light chains are required to maintain the stability of myosin II and cellular integrity.
Park I; Han C; Jin S; Lee B; Choi H; Kwon JT; Kim D; Kim J; Lifirsu E; Park WJ; Park ZY; Kim DH; Cho C
Biochem J; 2011 Feb; 434(1):171-80. PubMed ID: 21126233
[TBL] [Abstract][Full Text] [Related]
16. Mosaic loss of non-muscle myosin IIA and IIB is sufficient to induce mammary epithelial proliferation.
Nguyen-Ngoc KV; Silvestri VL; Georgess D; Fairchild AN; Ewald AJ
J Cell Sci; 2017 Oct; 130(19):3213-3221. PubMed ID: 28821574
[TBL] [Abstract][Full Text] [Related]
17. Calyculin A retraction of mature megakaryocytes proplatelets from embryonic stem cells.
Tamaru S; Kitajima K; Nakano T; Eto K; Yazaki A; Kobayashi T; Matsumoto T; Wada H; Katayama N; Nishikawa M
Biochem Biophys Res Commun; 2008 Feb; 366(3):763-8. PubMed ID: 18083116
[TBL] [Abstract][Full Text] [Related]
18. Abnormal megakaryocyte morphology and proplatelet formation in mice with megakaryocyte-restricted MYH9 inactivation.
Eckly A; Strassel C; Freund M; Cazenave JP; Lanza F; Gachet C; Léon C
Blood; 2009 Apr; 113(14):3182-9. PubMed ID: 18984861
[TBL] [Abstract][Full Text] [Related]
19. Input-specific regulation of hippocampal circuit maturation by non-muscle myosin IIB.
Ozkan ED; Aceti M; Creson TK; Rojas CS; Hubbs CR; McGuire MN; Kakad PP; Miller CA; Rumbaugh G
J Neurochem; 2015 Aug; 134(3):429-44. PubMed ID: 25931194
[TBL] [Abstract][Full Text] [Related]
20. Myosin-II repression favors pre/proplatelets but shear activation generates platelets and fails in macrothrombocytopenia.
Spinler KR; Shin JW; Lambert MP; Discher DE
Blood; 2015 Jan; 125(3):525-33. PubMed ID: 25395423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
